A study on 175 PD patients and 89 non-neurodegenerative controls, categorized by APOE4 carrier status, showed that APOE4 PD subjects have significantly lower levels of Aβ42 in CSF compared to both PD patients without APOE4 and the control group, independently of age. The gene discussed is APOE; the disease is Parkinson disease.